2021 annual financial data

Dermata Therapeutics, Inc. 2021 Operating margin

Dermata Therapeutics, Inc. 2021 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -7,856,864 USD and net income was -7,948,090 USD.
Operating cash flow was -5,693,392 USD.

Get free Dermata Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-7,856,864 USD
Net income
-7,948,090 USD
Operating cash flow
-5,693,392 USD